What is the current annual EBIT of SNY?

As of today, SNY annual EBIT is $10.28B

What is 1-year change in SNY annual EBIT?

SNY annual EBIT is up +22.14% year-over-year

What is 3-year change in SNY annual EBIT?

SNY annual EBIT is up +0.36% over the past 3 years

How far is SNY annual EBIT from its all-time high?

SNY annual EBIT is currently -2.46% below its historical high of $10.54B set on December 31, 2022

How does SNY annual EBIT rank versus sector peers?

SNY annual EBIT is higher than 99.24% of companies in Healthcare sector

When is SNY next annual earnings release?

The next annual earnings release for SNY is on January 29, 2026

What is the current quarterly EBIT of SNY?

As of today, SNY quarterly EBIT is $2.78B

What is SNY quarterly EBIT most recent change?

SNY quarterly EBIT was up +90.66% on September 30, 2022

What is 1-year change in SNY quarterly EBIT?

SNY quarterly EBIT is up +15.33% year-over-year

How far is SNY quarterly EBIT from its all-time high?

SNY quarterly EBIT is currently -73.90% below its historical high of $10.64B set on March 31, 2008

How does SNY quarterly EBIT rank versus sector peers?

SNY quarterly EBIT is higher than 98.93% of companies in Healthcare sector

When is SNY next earnings release?

The next earnings release for SNY is on January 29, 2026

What is the current TTM EBIT of SNY?

As of today, SNY TTM EBIT is $6.64B

What is SNY TTM EBIT most recent change?

SNY TTM EBIT was up +71.86% on September 30, 2022

What is 1-year change in SNY TTM EBIT?

SNY TTM EBIT is up +175.82% year-over-year

How far is SNY TTM EBIT from its all-time high?

SNY TTM EBIT is currently -49.87% below its historical high of $13.24B set on December 31, 2008

How does SNY TTM EBIT rank versus sector peers?

SNY TTM EBIT is higher than 98.30% of companies in Healthcare sector

When is SNY next earnings release?

The next earnings release for SNY is on January 29, 2026

Sanofi (SNY) EBIT History & Chart Since 1996

Annual EBIT

$10.28B$1.86B+22.14%

December 31, 2024

Summary

Current Value: As of today, SNY annual EBIT is $10.28B, up +22.14% on December 31, 2024
Historical Performance: SNY annual EBIT is up +0.36% over the past 3 years, and up +51.15% over the past 5 years
All-Time High Comparison: SNY annual EBIT is currently -2.46% below its historical high of $10.54B set on December 31, 2022
3-Year Low Comparison: SNY annual EBIT is +22.14% above its 3-year low of $8.42B reached on December 31, 2023
Sector Comparison: SNY annual EBIT is higher than 99.24% of companies in Healthcare sector

EBIT Chart

Add series to chart

Add series to chart1/6

Performance

SNY Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBIT	Dec 31, 24	$10.28B	+22.1%	+0.4%	+51.1%	+34.2%
Quarterly EBIT	Sep 30, 22	$2.78B	+15.3%	+15.3%	+15.3%	-71.0%
TTM EBIT	Sep 30, 22	$6.64B	+175.8%	+175.8%	+175.8%	-25.1%
Price	Jan 28, 26	$45.77	-13.6%	-5.6%	-3.8%	+37.2%
PE Ratio	Jan 28, 26	21.74	-13.6%	-5.6%	–	-85.5%
Annual Revenue	Dec 31, 24	$44.44B	+8.7%	-0.4%	+9.9%	+9.1%
Annual EPS	Dec 31, 24	$2.39	+3.0%	-18.1%	+85.0%	-14.6%
Annual EBITDA	Dec 31, 24	$14.21B	+7.1%	+1.9%	+29.2%	+2.0%
Annual Net Income	Dec 31, 24	$6.01B	+9.0%	-19.1%	+82.7%	-21.7%

EBIT Highs

SNY Annual EBIT Highs Comparison
Period	High	Date	Current
3Y	$10.54B	N/A	-2.5%
5Y	$10.54B	Dec 31, 22	-2.5%
All	$10.54B	Dec 31, 22	-2.5%

EBIT Lows

SNY Annual EBIT Lows Comparison
Period	Low	Date	Current
3Y	$8.42B	Dec 31, 23	+22.1%
5Y	$8.29B	N/A	+24.1%
All	-$4.08B	Dec 1, 98	+352.0%

EBIT History

Year	Value	Change
2024	$10.28B	+22.1%
2023	$8.42B	-20.1%
2022	$10.54B	+2.9%
2021	$10.25B	+23.6%
2020	$8.29B	+21.8%
2019	$6.80B	+13.5%
2018	$5.99B	-11.7%
2017	$6.79B	-8.9%
2016	$7.45B	+3.4%
2015	$7.20B	-12.7%
2014	$8.24B	+10.9%
2013	$7.43B	-12.7%
2012	$8.52B	+11.2%
2011	$7.66B	-10.2%
2010	$8.54B	+11.5%

Year	Value	Change
2009	$7.66B	+12.5%
2008	$6.81B	+12.3%
2007	$6.06B	+12.0%
2006	$5.41B	+31.8%
2005	$4.11B	+80.5%
2004	$2.27B	-25.2%
2003	$3.04B	+41.0%
2002	$2.16B	+32.2%
2001	$1.63B	+16.4%
2000	$1.40B	+35.6%
1999	$1.03B	+125.3%
1998	-$4.08B	-629.3%
1997	$770.98M	+1.2%
1996	$762.01M	-

FAQ

What is the current annual EBIT of SNY?
As of today, SNY annual EBIT is $10.28B
What is 1-year change in SNY annual EBIT?
SNY annual EBIT is up +22.14% year-over-year
What is 3-year change in SNY annual EBIT?
SNY annual EBIT is up +0.36% over the past 3 years
How far is SNY annual EBIT from its all-time high?
SNY annual EBIT is currently -2.46% below its historical high of $10.54B set on December 31, 2022
How does SNY annual EBIT rank versus sector peers?
SNY annual EBIT is higher than 99.24% of companies in Healthcare sector
When is SNY next annual earnings release?
The next annual earnings release for SNY is on January 29, 2026

Quarterly EBIT

$2.78B$1.32B+90.66%

September 30, 2022

Summary

Current Value: As of today, SNY quarterly EBIT is $2.78B, up +90.66% on September 30, 2022
Historical Performance: SNY quarterly EBIT is up +15.33% year-over-year, and up +15.33% over the past 3 years
All-Time High Comparison: SNY quarterly EBIT is currently -73.90% below its historical high of $10.64B set on March 31, 2008
3-Year Low Comparison: SNY quarterly EBIT is at its 3-year low
Sector Comparison: SNY quarterly EBIT is higher than 98.93% of companies in Healthcare sector

Performance

SNY Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBIT	Sep 30, 22	$2.78B	+90.7%	+15.3%	+15.3%	+15.3%
Annual EBIT	Dec 31, 24	$10.28B	–	+22.1%	+0.4%	+51.1%
TTM EBIT	Sep 30, 22	$6.64B	+71.9%	+175.8%	+175.8%	+175.8%
Price	Jan 28, 26	$45.77	-10.4%	-13.6%	-5.6%	-3.8%
PE Ratio	Jan 28, 26	21.74	-10.4%	-13.6%	-5.6%	–
Quarterly Revenue	Sep 30, 22	$13.14B	+22.3%	+30.7%	+30.7%	+30.7%
Quarterly EPS	Sep 30, 22	$0.83	+76.6%	+3.1%	+3.1%	+3.1%
Quarterly EBITDA	Sep 30, 22	$5.16B	+95.8%	+70.3%	+70.3%	+70.3%
Quarterly Net Income	Sep 30, 22	$2.08B	+76.7%	+3.3%	+3.3%	+3.3%

Quarterly EBIT Highs

SNY Quarterly EBIT Highs Comparison
Period	High	Date	Current
1Y	$2.78B	N/A	at high
3Y	$2.78B	N/A	at high
5Y	$2.78B	Sep 30, 22	at high
All	$10.64B	Mar 31, 08	-73.9%

Quarterly EBIT Lows

SNY Quarterly EBIT Lows Comparison
Period	Low	Date	Current
1Y	$2.78B	N/A	at low
3Y	$2.78B	N/A	at low
5Y	$1.46B	Jun 30, 22	+90.7%
All	-$21.72B	Dec 31, 07	+112.8%

Quarterly EBIT History

Month	Value	Change
Sep 2022	$2.78B	+90.7%
Jun 2022	$1.46B	-39.5%
Mar 2022	$2.41B	+59.7%
Mar 2015	$1.51B	-25.8%
Dec 2014	$2.03B	+17.9%
Dec 2013	$1.72B	-21.2%
Sep 2013	$2.19B	+12.0%
Mar 2013	$1.95B	-7.1%
Jun 2012	$2.10B	+29.1%
Jun 2011	$1.63B	+39.8%
Dec 2010	$1.16B	-39.9%
Dec 2009	$1.94B	-23.1%
Sep 2009	$2.52B	+45.2%
Jun 2009	$1.73B	-35.1%
Mar 2009	$2.67B	+170.5%
Dec 2008	-$3.79B	-196.7%
Sep 2008	$3.92B	+58.0%
Jun 2008	$2.48B	-76.7%
Mar 2008	$10.64B	+149.0%
Dec 2007	-$21.72B	-326.6%
Sep 2007	$9.59B	+327.0%

Month	Value	Change
Jun 2007	$2.25B	-75.7%
Mar 2007	$9.25B	+144.5%
Dec 2006	-$20.78B	-321.7%
Sep 2006	$9.37B	+580.8%
Jun 2006	$1.38B	-66.4%
Mar 2006	$4.09B	+187.5%
Dec 2005	-$4.68B	-207.3%
Sep 2005	$4.36B	+144.1%
Jun 2005	$1.79B	-66.0%
Mar 2005	$5.26B	+166.0%
Dec 2004	-$7.96B	-222.1%
Sep 2004	$6.52B	+608.2%
Jun 2004	$921.24M	-66.9%
Mar 2004	$2.78B	+173.1%
Dec 2003	-$3.81B	-239.9%
Sep 2003	$2.72B	+244.4%
Jun 2003	$789.90M	-62.2%
Mar 2003	$2.09B	+170.6%
Dec 2002	-$2.96B	-260.7%
Sep 2002	$1.84B	+224.9%
Jun 2002	$566.21M	-

FAQ

What is the current quarterly EBIT of SNY?
As of today, SNY quarterly EBIT is $2.78B
What is SNY quarterly EBIT most recent change?
SNY quarterly EBIT was up +90.66% on September 30, 2022
What is 1-year change in SNY quarterly EBIT?
SNY quarterly EBIT is up +15.33% year-over-year
How far is SNY quarterly EBIT from its all-time high?
SNY quarterly EBIT is currently -73.90% below its historical high of $10.64B set on March 31, 2008
How does SNY quarterly EBIT rank versus sector peers?
SNY quarterly EBIT is higher than 98.93% of companies in Healthcare sector
When is SNY next earnings release?
The next earnings release for SNY is on January 29, 2026

TTM EBIT

$6.64B$2.78B+71.86%

September 30, 2022

Summary

Current Value: As of today, SNY TTM EBIT is $6.64B, up +71.86% on September 30, 2022
Historical Performance: SNY TTM EBIT is up +175.82% year-over-year, and up +175.82% over the past 3 years
All-Time High Comparison: SNY TTM EBIT is currently -49.87% below its historical high of $13.24B set on December 31, 2008
3-Year Low Comparison: SNY TTM EBIT is at its 3-year low
Sector Comparison: SNY TTM EBIT is higher than 98.30% of companies in Healthcare sector

Performance

SNY Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBIT	Sep 30, 22	$6.64B	+71.9%	+175.8%	+175.8%	+175.8%
Annual EBIT	Dec 31, 24	$10.28B	–	+22.1%	+0.4%	+51.1%
Quarterly EBIT	Sep 30, 22	$2.78B	+90.7%	+15.3%	+15.3%	+15.3%
Price	Jan 28, 26	$45.77	-10.4%	-13.6%	-5.6%	-3.8%
PE Ratio	Jan 28, 26	21.74	-10.4%	-13.6%	-5.6%	–
TTM Revenue	Sep 30, 22	$33.93B	+63.2%	+237.5%	+237.5%	+237.5%
TTM EPS	Sep 30, 22	$2.11	+65.1%	+161.5%	+161.5%	+161.5%
TTM EBITDA	Sep 30, 22	$10.83B	+91.1%	+257.3%	+257.3%	+257.3%
TTM Net Income	Sep 30, 22	$5.26B	+65.2%	+161.8%	+161.8%	+161.8%

TTM EBIT Highs

SNY TTM EBIT Highs Comparison
Period	High	Date	Current
1Y	$6.64B	N/A	at high
3Y	$6.64B	N/A	at high
5Y	$6.64B	Sep 30, 22	at high
All	$13.24B	Dec 31, 08	-49.9%

TTM EBIT Lows

SNY TTM EBIT Lows Comparison
Period	Low	Date	Current
1Y	$6.64B	N/A	at low
3Y	$6.64B	N/A	at low
5Y	$2.41B	Mar 31, 22	+175.8%
All	-$5.94B	Dec 31, 06	+211.9%

TTM EBIT History

Month	Value	Change
Sep 2022	$6.64B	+71.9%
Jun 2022	$3.86B	+60.5%
Mar 2022	$2.41B	-32.0%
Mar 2015	$3.54B	+74.2%
Dec 2014	$2.03B	-65.3%
Dec 2013	$5.86B	+41.6%
Sep 2013	$4.14B	+2.1%
Mar 2013	$4.05B	+92.9%
Jun 2012	$2.10B	-24.7%
Jun 2011	$2.79B	+139.8%
Dec 2010	$1.16B	-86.9%
Dec 2009	$8.86B	+182.7%
Sep 2009	$3.13B	-30.9%
Jun 2009	$4.54B	-14.1%
Mar 2009	$5.28B	-60.1%
Dec 2008	$13.24B	+382.6%
Sep 2008	-$4.69B	-578.0%
Jun 2008	$980.43M	+31.6%
Mar 2008	$744.95M	+215.7%
Dec 2007	-$643.73M	-316.8%
Sep 2007	$296.96M	+249.9%

Month	Value	Change
Jun 2007	$84.87M	+110.8%
Mar 2007	-$783.24M	+86.8%
Dec 2006	-$5.94B	-158.4%
Sep 2006	$10.16B	+97.2%
Jun 2006	$5.15B	-7.4%
Mar 2006	$5.56B	-17.3%
Dec 2005	$6.73B	+95.2%
Sep 2005	$3.45B	-38.5%
Jun 2005	$5.61B	+18.3%
Mar 2005	$4.74B	+109.6%
Dec 2004	$2.26B	-64.8%
Sep 2004	$6.42B	+145.2%
Jun 2004	$2.62B	+5.3%
Mar 2004	$2.49B	+38.7%
Dec 2003	$1.79B	-32.1%
Sep 2003	$2.64B	+50.0%
Jun 2003	$1.76B	+14.5%
Mar 2003	$1.54B	+379.6%
Dec 2002	-$549.94M	-122.9%
Sep 2002	$2.41B	+324.9%
Jun 2002	$566.21M	-

FAQ

What is the current TTM EBIT of SNY?
As of today, SNY TTM EBIT is $6.64B
What is SNY TTM EBIT most recent change?
SNY TTM EBIT was up +71.86% on September 30, 2022
What is 1-year change in SNY TTM EBIT?
SNY TTM EBIT is up +175.82% year-over-year
How far is SNY TTM EBIT from its all-time high?
SNY TTM EBIT is currently -49.87% below its historical high of $13.24B set on December 31, 2008
How does SNY TTM EBIT rank versus sector peers?
SNY TTM EBIT is higher than 98.30% of companies in Healthcare sector
When is SNY next earnings release?
The next earnings release for SNY is on January 29, 2026

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

Data Sources & References

SNY Official Website www.sanofi.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1121404/000112140425000010/0001121404-25-000010-index.htm
SNY Profile on Yahoo Finance finance.yahoo.com/quote/SNY
SNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sny